Single User License: $2750
Member Price: FREE
Use code SUMMER at checkout for 50% OFF
Already a member? Login to access this report free.
Report Highlights
The global market for rapid medical diagnostic kits (MDK) was $16.5 billion in 2011 and nearly $18.4 billion in 2012. This market is expected to reach $24.2 billion in 2017, at an estimated compound annual growth rate (CAGR) of 5.7% from 2012 to 2017.
Report Includes
- An overview of the market for rapid medical diagnostic kits, with an intensive examination of the in vitro diagnostic kit segment of the medical device market.
- Analyses of market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017.
- Discussion of changes that have occurred over the last five years as the result of technological advances and regulatory implementations, and the impact those changes will have on the overall market and key market segments.
- Examination of the effect on the market of inexpensive, automated testing devices, known as point-of-care (POC) instruments, which have replaced MDKs in smaller laboratories and physicians’ offices.
- Emerging marketing practices, such as strategic alliances and acquisitions.
- Coverage of the effect of external market forces, such as insurance and increased incidence of disease.
SCOPE OF REPORT
The report concentrates on rapid MDK and their position in the overall MDK market. The report specifically excludes tests that involve automated testing or tests that require processing devices and semiautomated batch testing devices.
The rapid MDK market encapsulates current and potential products, related technologies, components and component suppliers, end markets, governmental and regulatory agencies, major companies competing in this market, relative market shares and the impact of the worldwide market status.
This study defines the MDK market and provides detailed information on the following:
- Products that comprise the rapid MDK industry.
- Emerging and current MDK technologies.
- Analysis of these technologies and the effect on future market development.
- Market structure and current market size, with forecasts by type of product and market region from 2012 to 2017.
- The effect of external market forces, such as insurance, regulatory and economic issues and increased incidence of disease.
ANALYST CREDENTIALS
Peggy S. Lehr is the BCC research analyst of this report. Ms. Lehr holds a BS in Journalism from the University of Colorado, Boulder, and a MS in Communication from the University of Denver. Ms. Lehr has been involved with the medical/nursing industry for more than 20 years, and she has worked within the publishing industry for both for-profit and not-for-profit organizations. Recent reports for BCC include seven healthcare reports and her latest report, PHM061B, on the global infectious disease market.
Report Highlights
- The U.S. market for medical diagnostic kits (MDKs) increased from $11.2 billion in 2007 to an estimated $12.2 billion by the end of 2008. It should reach $18.5 billion in 2013, a compound annual growth rate (CAGR) of 8.7%.
- MDKs accounted for approximately 23% of all clinical diagnostic testing in the U.S. in 2007. With the increased market share by instrumentation suites, this share is expected to decline to 20% by 2013.
- Point-of-care (POC) instruments have affected the use of MDKs because of the benefits they offer including improved cost efficiencies and rapid results.
Report Highlights
-
In 2001, sales at the U.S. manufacturers level exceeded $3.8 billion. By 2006, the market is anticipated to grow at an average annual rate (AAGR) of 6.2% to yield sales of more than $5.1 billion.
-
MDKs accounted for 34.6% of all diagnostic testing in the U.S. in 2001 and by 2006, market share will drop to 30.8%.
-
Point-of-care (POC) instruments have impacted the use of MDKs because of the benefits they offer for improving patient care.
-
The veterinary MDK segment has not developed as previously expected. Sales to this segment only reached an estimated $296 million in 2001 and the AAGR is projected to be only 2% through 2006.
-
Scientific advances resulting from the study of the human genome have fueled an increase in the use of MDKs in the research segment. Average annual growth is expected to be 10.5% through 2006.
Recent Reports
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.
Routine Health Screening Market
The global market for routine health screening is expected to grow from $59.7 billion in 2024 and is projected to reach $82.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.
Elder Care Services and Assistive Devices: Global Markets
The global market for elder care services and assistive devices is expected to grow from $868.2 billion in 2024 and is projected to reach $1.1 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.
Direct-to-Consumer Testing Industry: Global Markets
The global market for direct-to-consumer (DTC) testing is estimated to increase from $1.6 billion in 2023 to reach $3.2 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.
Health and Medical Insurance Providers: Global Markets
The global market for health and medical insurance providers is expected to grow from $2.2 trillion in 2023 to $3.4 trillion by the end of 2028, at a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2023 to 2028.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More